Affiliations

NYBA

Australia Biotech

BioMelbourne

Lab To Wall Street

The Firm

O'Sullivan PLLC is based in New York City and has a global reach and perspective. We offer clear, timely and cost-effective counsel to companies, institutions and individuals involved in virtually any area of the heathcare, life scienceÊand technology sectors.

We are available to counsel clients regarding: domestic and international collaboration and commercialization, technology transfer, capital raising, mergers and acquisitions, Securities and Exchange Commission requirements, government regulation, intellectual property development, strategy and protection, and complex litigation.

To schedule a consultation, please call or email us at info@osullivanpllc.com.

The Firm

O'Sullivan PLLC's goal is to provide its clients with the very best legal counsel through all phases of commercial development. Whether navigating the regulatory processes, collaborating with other individuals or entities, or mediating or litigating a dispute, O'Sullivan PLLC is committed to representing its clients in an intelligent, efficient and cost-effective manner with the highest level of professional ethics.

  November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins

August 6th:
Xenome Strengthens Board with Two New Appointments

August 6th:
Ciba Elects to Cease Industrial Product Evaluations

June 24th:
New Pharmaxis Board Appointment

April 29th:
Benitec secures further rights to HIV Therapeutic

April 7th:
Starpharma signs agreement with Unilever

April 1st:
ChemGenex Investigators Present Data on Omacetaxine at International Leukemia Conference

more industry news >
 


osullivanpllc.com  

Disclaimer